You have free access to this content

Hepatology

Cover image for Hepatology

May 2010

Volume 51, Issue 5

Pages 1479–1868

  1. Public Policy Corner

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
  2. Comments from the Editors

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
  3. Editorials

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Fatty liver: Think globally (pages 1491–1493)

      James E. Everhart and Kiran M. Bambha

      Version of Record online: 8 MAR 2010 | DOI: 10.1002/hep.23659

  4. Viral Hepatitis

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Hepatitis C virus core protein interacts with fibrinogen-β and attenuates cytokine stimulated acute-phase response (pages 1505–1513)

      Malika Ait-Goughoulte, Arup Banerjee, Keith Meyer, Budhaditya Mazumdar, Kousuke Saito, Ratna B. Ray and Ranjit Ray

      Version of Record online: 10 DEC 2009 | DOI: 10.1002/hep.23502

    3. You have free access to this content
      Specific human leukocyte antigen class I and II alleles associated with hepatitis C virus viremia (pages 1514–1522)

      Mark H. Kuniholm, Andrea Kovacs, Xiaojiang Gao, Xiaonan Xue, Darlene Marti, Chloe L. Thio, Marion G. Peters, Norah A. Terrault, Ruth M. Greenblatt, James J. Goedert, Mardge H. Cohen, Howard Minkoff, Stephen J. Gange, Kathryn Anastos, Melissa Fazzari, Tiffany G. Harris, Mary A. Young, Howard D. Strickler and Mary Carrington

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23515

    4. You have free access to this content
      Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis C (pages 1523–1530)

      Galia Askarieh, Åsa Alsiö, Paolo Pugnale, Francesco Negro, Carlo Ferrari, Avidan U. Neumann, Jean-Michel Pawlotsky, Solko W. Schalm, Stefan Zeuzem, Gunnar Norkrans, Johan Westin, Jonas Söderholm, Kristoffer Hellstrand, Martin Lagging and DITTO-HCV and NORDynamIC Study Groups

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23509

    5. You have free access to this content
      Clearance of hepatitis B surface antigen and risk of hepatocellular carcinoma in a cohort chronically infected with hepatitis B virus (pages 1531–1537)

      Josephine Simonetti, Lisa Bulkow, Brian J. McMahon, Chriss Homan, Mary Snowball, Susan Negus, James Williams and Stephen E. Livingston

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23464

      Corrected by:

      Correction: Correction

      Vol. 62, Issue 4, 1330, Version of Record online: 7 AUG 2015

    6. You have free access to this content
    7. You have free access to this content
      Determination of immune memory to hepatitis B vaccination through early booster response in college students (pages 1547–1554)

      Chyi-Feng Jan, Kuo-Chin Huang, Yin-Chu Chien, Donald E. Greydanus, H. Dele Davies, Tai-Yuan Chiu, Li-Min Huang, Chien-Jen Chen and Ding-Shinn Chen

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23543

  5. Steatohepatitis/Metabolic Liver Disease

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Cigarette smoking exacerbates nonalcoholic fatty liver disease in obese rats (pages 1567–1576)

      Lorenzo Azzalini, Elisabet Ferrer, Leandra N. Ramalho, Montserrat Moreno, Marlene Domínguez, Jordi Colmenero, Víctor I. Peinado, Joan A. Barberà, Vicente Arroyo, Pere Ginès, Joan Caballería and Ramón Bataller

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23516

    3. You have free access to this content
      Estimation of the healthy upper limits for serum alanine aminotransferase in Asian populations with normal liver histology (pages 1577–1583)

      Jae Keun Lee, Ju Hyun Shim, Han Chu Lee, Sae Hwan Lee, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee and Dong Jin Suh

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23505

    4. You have free access to this content
      Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway (pages 1584–1592)

      Nitika Arora Gupta, Jamie Mells, Richard M. Dunham, Arash Grakoui, Jeffrey Handy, Neeraj Kumar Saxena and Frank A. Anania

      Version of Record online: 1 FEB 2010 | DOI: 10.1002/hep.23569

    5. You have free access to this content
      Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease (pages 1593–1602)

      Kausik Das, Kshaunish Das, Partha S. Mukherjee, Alip Ghosh, Sumantra Ghosh, Asit R. Mridha, Tapan Dhibar, Bhaskar Bhattacharya, Dilip Bhattacharya, Byomkesh Manna, Gopal K. Dhali, Amal Santra and Abhijit Chowdhury

      Version of Record online: 1 FEB 2010 | DOI: 10.1002/hep.23567

  6. Hepatobiliary Malignancies

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Accelerated liver regeneration and hepatocarcinogenesis in mice overexpressing serine-45 mutant β-catenin (pages 1603–1613)

      Kari N. Nejak-Bowen, Michael D. Thompson, Sucha Singh, William C. Bowen Jr., Mohd Jamal Dar, Jaspal Khillan, Chunsun Dai and Satdarshan P.S. Monga

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23538

    2. You have free access to this content
    3. You have free access to this content
      Down-regulation of tyrosine aminotransferase at a frequently deleted region 16q22 contributes to the pathogenesis of hepatocellular carcinoma (pages 1624–1634)

      Li Fu, Sui-Sui Dong, Yi-Wu Xie, Lai-Shan Tai, Leilei Chen, Kar Lok Kong, Kwan Man, Dan Xie, Yan Li, Yingduan Cheng, Qian Tao and Xin-Yuan Guan

      Version of Record online: 1 FEB 2010 | DOI: 10.1002/hep.23540

    4. You have free access to this content
  7. Autoimmune, Cholestatic and Biliary Disease

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      ATP8B1 and ABCB11 analysis in 62 children with normal gamma-glutamyl transferase progressive familial intrahepatic cholestasis (PFIC): Phenotypic differences between PFIC1 and PFIC2 and natural history (pages 1645–1655)

      Anne Davit-Spraul, Monique Fabre, Sophie Branchereau, Christiane Baussan, Emmanuel Gonzales, Bruno Stieger, Olivier Bernard and Emmanuel Jacquemin

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23539

    2. You have free access to this content
      A role for the pregnane X receptor in flucloxacillin-induced liver injury (pages 1656–1664)

      Elise Andrews, Martin Armstrong, Jonathan Tugwood, Dan Swan, Philip Glaves, Munir Pirmohamed, Guruprasad P. Aithal, Matthew C. Wright, Christopher P. Day and Ann K. Daly

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23549

  8. Liver Failure/Cirrhosis/Portal Hypertension

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Antituberculosis therapy–induced acute liver failure: Magnitude, profile, prognosis, and predictors of outcome (pages 1665–1674)

      Ramesh Kumar, Shalimar, Vikram Bhatia, Shankar Khanal, V. Sreenivas, S. Datta Gupta, Subrat K. Panda and Subrat K. Acharya

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23534

    2. You have free access to this content
      Clinical course of alcoholic liver cirrhosis: A Danish population-based cohort study (pages 1675–1682)

      Peter Jepsen, Peter Ott, Per Kragh Andersen, Henrik Toft Sørensen and Hendrik Vilstrup

      Version of Record online: 9 DEC 2009 | DOI: 10.1002/hep.23500

    3. You have free access to this content
      Serum ferritin concentration predicts mortality in patients awaiting liver transplantation (pages 1683–1691)

      Nicole M. Walker, Katherine A. Stuart, Rebecca J. Ryan, Shireena Desai, Sammy Saab, Jennifer A. Nicol, Linda M. Fletcher and Darrell H. G. Crawford

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23537

  9. Liver Injury/Regeneration

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Critical role of interferon regulatory factor-1 in murine liver transplant ischemia reperfusion injury (pages 1692–1701)

      Shinya Ueki, Rajeev Dhupar, Jon Cardinal, Allan Tsung, Junichi Yoshida, Kikumi S. Ozaki, John R. Klune, Noriko Murase and David A. Geller

      Version of Record online: 9 DEC 2009 | DOI: 10.1002/hep.23501

    2. You have free access to this content
      Deletion of CD39 on natural killer cells attenuates hepatic ischemia/reperfusion injury in mice (pages 1702–1711)

      Guido Beldi, Yara Banz, Alexander Kroemer, Xiaofeng Sun, Yan Wu, Nadine Graubardt, Alyssa Rellstab, Martina Nowak, Keiichi Enjyoji, Xian Li, Wolfgang G. Junger, Daniel Candinas and Simon C. Robson

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23510

    3. You have free access to this content
      Hedgehog signaling is critical for normal liver regeneration after partial hepatectomy in mice (pages 1712–1723)

      Begoña Ochoa, Wing-Kin Syn, Igotz Delgado, Gamze F. Karaca, Youngmi Jung, Jiangbo Wang, Ana M. Zubiaga, Olatz Fresnedo, Alessia Omenetti, Marzena Zdanowicz, Steve S. Choi and Anna Mae Diehl

      Version of Record online: 15 JAN 2010 | DOI: 10.1002/hep.23525

    4. You have free access to this content
      Dissociation between liver inflammation and hepatocellular damage induced by carbon tetrachloride in myeloid cell–specific signal transducer and activator of transcription 3 gene knockout mice (pages 1724–1734)

      Norio Horiguchi, Fouad Lafdil, Andrew M. Miller, Ogyi Park, Hua Wang, Mohanraj Rajesh, Partha Mukhopadhyay, Xin Yuan Fu, Pal Pacher and Bin Gao

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23532

    5. You have free access to this content
      MicroRNAs control hepatocyte proliferation during liver regeneration (pages 1735–1743)

      Guisheng Song, Amar Deep Sharma, Garrett R. Roll, Raymond Ng, Andrew Y. Lee, Robert H. Blelloch, Niels M. Frandsen and Holger Willenbring

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23547

  10. Liver Biology/Pathobiology

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Caveolin-1 is enriched in the peroxisomal membrane of rat hepatocytes (pages 1744–1753)

      Jannes Woudenberg, Krzysztof P. Rembacz, Fiona A. J. van den Heuvel, Titia E. Woudenberg-Vrenken, Manon Buist-Homan, Mariska Geuken, Mark Hoekstra, Leo E. Deelman, Carlos Enrich, Rob H. Henning, Han Moshage and Klaas Nico Faber

      Version of Record online: 30 NOV 2009 | DOI: 10.1002/hep.23460

    2. You have free access to this content
      Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development (pages 1754–1765)

      Thomas Touboul, Nicholas R. F. Hannan, Sébastien Corbineau, Amélie Martinez, Clémence Martinet, Sophie Branchereau, Sylvie Mainot, Hélène Strick-Marchand, Roger Pedersen, James Di Santo, Anne Weber and Ludovic Vallier

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23506

    3. You have free access to this content
      Vitamin C deficiency attenuates liver fibrosis by way of up-regulated peroxisome proliferator-activated receptor-gamma expression in senescence marker protein 30 knockout mice (pages 1766–1777)

      Jin-Kyu Park, Mi-Ran Ki, Hye-Rim Lee, Il-Hwa Hong, Ae-Ri Ji, Akihito Ishigami, Se-Il Park, Ji-Min Kim, Hae-Young Chung, Sung-Eun Yoo and Kyu-Shik Jeong

      Version of Record online: 9 DEC 2009 | DOI: 10.1002/hep.23499

    4. You have free access to this content
      Mammalian target of rapamycin regulates vascular endothelial growth factor–dependent liver cyst growth in polycystin-2–defective mice (pages 1778–1788)

      Carlo Spirli, Stefano Okolicsanyi, Romina Fiorotto, Luca Fabris, Massimiliano Cadamuro, Silvia Lecchi, Xin Tian, Stefan Somlo and Mario Strazzabosco

      Version of Record online: 23 DEC 2009 | DOI: 10.1002/hep.23511

    5. You have free access to this content
      Forkhead box p3+ regulatory T cell underlies male resistance to experimental type 2 autoimmune hepatitis (pages 1789–1798)

      Pascal Lapierre, Kathie Béland, Caroline Martin, Fernando Alvarez Jr. and Fernando Alvarez

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23536

    6. You have free access to this content
      Hepatic glycosphingolipid deficiency and liver function in mice (pages 1799–1809)

      Richard Jennemann, Ulrike Rothermel, Shijun Wang, Roger Sandhoff, Sylvia Kaden, Ruud Out, Theo J. van Berkel, Johannes M. Aerts, Karen Ghauharali, Carsten Sticht and Hermann-Josef Gröne

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23545

  11. Rapid Communication

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Generation of endoderm-derived human induced pluripotent stem cells from primary hepatocytes (pages 1810–1819)

      Hua Liu, Zhaohui Ye, Yonghak Kim, Saul Sharkis and Yoon-Young Jang

      Version of Record online: 1 MAR 2010 | DOI: 10.1002/hep.23626

  12. Reviews

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection (pages 1820–1832)

      Brad Q. Starley, Christopher J. Calcagno and Stephen A. Harrison

      Version of Record online: 12 FEB 2010 | DOI: 10.1002/hep.23594

    2. You have free access to this content
      The utility of genome-wide association studies in hepatology (pages 1833–1842)

      Tom H. Karlsen, Espen Melum and Andre Franke

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23564

  13. Diagnostic and Therapeutic Advances in Hepatology

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Drug therapy: Sorafenib (pages 1843–1849)

      Richard S. Finn

      Version of Record online: 23 MAR 2010 | DOI: 10.1002/hep.23676

  14. Hepatology Elsewhere

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Hepatitis C virus infection in living color (pages 1852–1855)

      Nicholas S. Eyre and Michael R. Beard

      Version of Record online: 23 APR 2010 | DOI: 10.1002/hep.23695

  15. Image of the Month

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
  16. Correspondence

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
      Fibrosis in liver as a predictive marker for hepatitis C virus therapy (page 1858)

      Akif AltInbaş, Şahin Coban and Osman Yüksel

      Version of Record online: 1 MAR 2010 | DOI: 10.1002/hep.23629

    2. You have free access to this content
      Reply: Fibrosis in liver as a predictive marker for hepatitis C virus therapy (page 1858)

      Salvatore Petta and Antonio Craxì

      Version of Record online: 1 MAR 2010 | DOI: 10.1002/hep.23646

    3. You have free access to this content
      Is oil red-O staining and digital image analysis the gold standard for quantifying steatosis in the liver? (page 1859)

      Adam P. Levene, Hiromi Kudo, Mark R. Thursz, Quentin M. Anstee and Robert D. Goldin

      Version of Record online: 28 JAN 2010 | DOI: 10.1002/hep.23551

    4. You have free access to this content
    5. You have free access to this content
    6. You have free access to this content
      Reply: Comments on AASLD practice guidelines for alcoholic liver disease (page 1861)

      Arthur McCullough, Srinivasan Dasarathy and Robert O'Shea

      Version of Record online: 8 MAR 2010 | DOI: 10.1002/hep.23652

    7. You have free access to this content
    8. You have free access to this content
    9. You have free access to this content
    10. You have free access to this content
      Reply: Adjunctive vitamin E treatment in Wilson disease and suggestions for future trials (pages 1864–1865)

      Roderick H. J. Houwen, Francisca H. H. Linn and Karel J. van Erpecum

      Version of Record online: 23 MAR 2010 | DOI: 10.1002/hep.23687

    11. You have free access to this content
    12. You have free access to this content
    13. You have free access to this content
      Thiazolidinediones as potent inducers of hepatocyte growth factor (pages 1866–1867)

      Wataru Ito, Shigeharu Ueki, Masahide Takeda, Tomomi Tanigai, Hiroyuki Kayaba and Junichi Chihara

      Version of Record online: 8 DEC 2009 | DOI: 10.1002/hep.23491

  17. Corrections

    1. Top of page
    2. Public Policy Corner
    3. Comments from the Editors
    4. Editorials
    5. Viral Hepatitis
    6. Steatohepatitis/Metabolic Liver Disease
    7. Hepatobiliary Malignancies
    8. Autoimmune, Cholestatic and Biliary Disease
    9. Liver Failure/Cirrhosis/Portal Hypertension
    10. Liver Injury/Regeneration
    11. Liver Biology/Pathobiology
    12. Rapid Communication
    13. Reviews
    14. Diagnostic and Therapeutic Advances in Hepatology
    15. Hepatology Elsewhere
    16. Image of the Month
    17. Correspondence
    18. Corrections
    1. You have free access to this content
    2. You have free access to this content
      Correction: Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial (page 1868)

      Manal F. Abdelmalek, Schuyler O. Sanderson, Paul Angulo, Consuelo Soldevila-Pico, Chen Liu, Joy Peter, Jill Keach, Matt Cave, Theresa Chen, Craig J. McClain and Keith D. Lindor

      Version of Record online: 23 APR 2010 | DOI: 10.1002/hep.23642

      This article corrects:

      Betaine for nonalcoholic fatty liver disease: Results of a randomized placebo-controlled trial1

      Vol. 50, Issue 6, 1818–1826, Version of Record online: 17 AUG 2009

SEARCH

SEARCH BY CITATION